KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Other Working Capital Changes (2017 - 2025)

Elanco Animal Health (ELAN) has disclosed Other Working Capital Changes for 9 consecutive years, with $52.0 million as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes fell 45.83% to $52.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$6.0 million through Dec 2025, down 300.0% year-over-year, with the annual reading at -$6.0 million for FY2025, 300.0% down from the prior year.
  • Other Working Capital Changes hit $52.0 million in Q4 2025 for Elanco Animal Health, up from -$243.0 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $439.0 million in Q1 2023 to a low of -$440.0 million in Q4 2023.
  • Historically, Other Working Capital Changes has averaged $6.1 million across 5 years, with a median of $9.5 million in 2021.
  • Biggest five-year swings in Other Working Capital Changes: skyrocketed 18500.0% in 2021 and later plummeted 735.29% in 2024.
  • Year by year, Other Working Capital Changes stood at -$232.0 million in 2021, then fell by 18.97% to -$276.0 million in 2022, then plummeted by 59.42% to -$440.0 million in 2023, then skyrocketed by 121.82% to $96.0 million in 2024, then tumbled by 45.83% to $52.0 million in 2025.
  • Business Quant data shows Other Working Capital Changes for ELAN at $52.0 million in Q4 2025, -$243.0 million in Q3 2025, and -$52.0 million in Q2 2025.